Overview
Pulmonary insufficiency following shock involves compromised gas exchange and hemodynamic instability, often necessitating advanced supportive measures due to systemic interactions and potential progression to fibrosis 12.Diagnosis
Assess arterial oxygen tension (pO2) and oxygen content to evaluate hypoxemia 3.
Evaluate lactate and pyruvate levels; elevated levels often correlate with systemic circulatory disorders rather than pulmonary insufficiency alone 3.
Consider pulmonary insufficiency index (PII) for patient selection in severe cases 2.Management
First-line treatments: Extracorporeal membrane oxygenation (ECMO) for selected patients with refractory pulmonary insufficiency 2.
Adjunctive therapies: Focus on managing underlying shock and systemic perfusion issues to prevent progression to fibrosis 12.
Monitoring: Regular assessment of hemodynamic parameters and oxygenation status 1.Special Populations
Pediatrics: ECMO shows promising outcomes, particularly in postoperative cardiac failure cases 2.
Adults with capillary leak syndromes: Also benefit from ECMO support, though outcomes vary 2.Key Recommendations
Use ECMO as a lifesaving intervention in selected cases of severe pulmonary insufficiency following shock (Evidence: Moderate) 2.
Monitor blood lactate and pyruvate levels to differentiate systemic circulatory disorders from isolated pulmonary insufficiency (Evidence: Weak) 3.
Tailor patient selection for ECMO based on clinical criteria such as PII and hemodynamic stability (Evidence: Expert opinion) 2.References
1 Rosenthal M. Hemodynamic effects of pulmonary insufficiency. International anesthesiology clinics 1986. link
2 Bartlett RH, Gazzaniga AB, Fong SW, Jefferies MR, Roohk HV, Haiduc N. Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases. The Journal of thoracic and cardiovascular surgery 1977. link
3 Eldridge F. Blood lactate and pyruvate in pulmonary insufficiency. The New England journal of medicine 1966. link